Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Adherence to Long-Term Therapies: Evidence for Action

Adherence to Long-Term Therapies: Evidence for Action Downloaded from https://academic.oup.com/eurjcn/article/2/4/323/5929167 by DeepDyve user on 09 October 2022 European Journal of Cardiovascular Nursing 2 (2003) 323 Letter to the editor Adherence to long-term therapies: evidence for The value of this WHO report is not only that it com- action prehensively reviews the current state of the literature including hypertension and tobacco smoking cessation, but also it highlights the need for a multi-disciplinary The World Health Organization (WHO) has recently approach to adherence, emphasizes system factors that published a comprehensive report entitled Adherence to need to be addressed in successfully implementing w x Long-Term Therapies: Evidence for Action 1 . This adherence-enhancing strategies. Moreover, it also pro- report focuses on nine chronic conditions and their risk- vides illustrative examples of the ways in which profes- factors. The conditions reviewed are hypertension, sionals have contributed in their own fields of expertise tobacco smoking cessation, asthma, cancer (palliative including cardiovascular care among other fields. This care), depression, diabetes, epilepsy, HIVyAIDS and report, therefore, provides an instrument to cardiovas- tuberculosis. cular nurses to expand the behavioral dimension of their The report reviewed the available literature on the epi- patient management strategies, to teach students at demiology of nonadherence worldwide; it stressed the undergraduate and graduate level, to guide their research multi-factorial nature of nonadherence, it identified endeavors, to guide policy makers, ultimately with the health systems and health care teams as significant deter- goal to improve outcomes of populations. minants to good adherence and discussed the health and economic consequences of nonadherence as well as References some strategies for improving it. w x ´ 1 Sabate E, editor. Adherence to long-term therapies: evidence This reporthas major relevance for cardiovascular for action. Geneva, Switzerland: World Health Organization, nurses. Cardiovascular disease is and will remain a major 2003. (available at http:yywww.who.intychronic_conditionsy adherencereportyeny). challenge for health care professionals and health care w x 2 World Health Organization. Innovative care for chronic con- systems, and it contributes significantly to the global ditions. Building blocks for action: global report. Geneva: burden of disease in both developed and developing w x WHO; 2002 ISBN 9241590173 . w x countries 2 . Nonadherence to treatment recommenda- w x 3 Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with car- tions in patients with cardiovascular risk-factors as well diovascular disease prevention strategies: a review of the research. Ann Behav Med 1997;19(3):239 –63. as patients with cardiovascular disease is widespread, Sabina De Geest and it is a major factor contributing to poor outcome. Institute of Nursing Science, University of Basel, Nurses are excellently positioned to target the behavioral Bernoullistrasse 28, CH-4056 Basel, Switzerland dimension of chronic disease management. They can E-mail address: [email protected] improve outcomes by developing and implementing Eduardo Sabate adherence-enhancing strategies to reduce cardiovascular WHOyOMS – NMH 4059, 20, Avenue Appia, CH 1211 Geneva 27, risk-factors, and to enhance adherence with non-smok- Switzerland w x ing, diet, exercise and medication regimens 3 . E-mail address: [email protected] 1474-5151/03/$30.00  2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved. doi:10.1016/S1474-5151(03)00091-4 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cardiovascular Nursing Oxford University Press

Adherence to Long-Term Therapies: Evidence for Action

Loading next page...
 
/lp/oxford-university-press/adherence-to-long-term-therapies-evidence-for-action-3HQkpoQ27A

References (2)

Publisher
Oxford University Press
Copyright
Copyright © 2022 European Society of Cardiology
ISSN
1474-5151
eISSN
1873-1953
DOI
10.1016/s1474-5151(03)00091-4
Publisher site
See Article on Publisher Site

Abstract

Downloaded from https://academic.oup.com/eurjcn/article/2/4/323/5929167 by DeepDyve user on 09 October 2022 European Journal of Cardiovascular Nursing 2 (2003) 323 Letter to the editor Adherence to long-term therapies: evidence for The value of this WHO report is not only that it com- action prehensively reviews the current state of the literature including hypertension and tobacco smoking cessation, but also it highlights the need for a multi-disciplinary The World Health Organization (WHO) has recently approach to adherence, emphasizes system factors that published a comprehensive report entitled Adherence to need to be addressed in successfully implementing w x Long-Term Therapies: Evidence for Action 1 . This adherence-enhancing strategies. Moreover, it also pro- report focuses on nine chronic conditions and their risk- vides illustrative examples of the ways in which profes- factors. The conditions reviewed are hypertension, sionals have contributed in their own fields of expertise tobacco smoking cessation, asthma, cancer (palliative including cardiovascular care among other fields. This care), depression, diabetes, epilepsy, HIVyAIDS and report, therefore, provides an instrument to cardiovas- tuberculosis. cular nurses to expand the behavioral dimension of their The report reviewed the available literature on the epi- patient management strategies, to teach students at demiology of nonadherence worldwide; it stressed the undergraduate and graduate level, to guide their research multi-factorial nature of nonadherence, it identified endeavors, to guide policy makers, ultimately with the health systems and health care teams as significant deter- goal to improve outcomes of populations. minants to good adherence and discussed the health and economic consequences of nonadherence as well as References some strategies for improving it. w x ´ 1 Sabate E, editor. Adherence to long-term therapies: evidence This reporthas major relevance for cardiovascular for action. Geneva, Switzerland: World Health Organization, nurses. Cardiovascular disease is and will remain a major 2003. (available at http:yywww.who.intychronic_conditionsy adherencereportyeny). challenge for health care professionals and health care w x 2 World Health Organization. Innovative care for chronic con- systems, and it contributes significantly to the global ditions. Building blocks for action: global report. Geneva: burden of disease in both developed and developing w x WHO; 2002 ISBN 9241590173 . w x countries 2 . Nonadherence to treatment recommenda- w x 3 Burke LE, Dunbar-Jacob JM, Hill MN. Compliance with car- tions in patients with cardiovascular risk-factors as well diovascular disease prevention strategies: a review of the research. Ann Behav Med 1997;19(3):239 –63. as patients with cardiovascular disease is widespread, Sabina De Geest and it is a major factor contributing to poor outcome. Institute of Nursing Science, University of Basel, Nurses are excellently positioned to target the behavioral Bernoullistrasse 28, CH-4056 Basel, Switzerland dimension of chronic disease management. They can E-mail address: [email protected] improve outcomes by developing and implementing Eduardo Sabate adherence-enhancing strategies to reduce cardiovascular WHOyOMS – NMH 4059, 20, Avenue Appia, CH 1211 Geneva 27, risk-factors, and to enhance adherence with non-smok- Switzerland w x ing, diet, exercise and medication regimens 3 . E-mail address: [email protected] 1474-5151/03/$30.00  2003 European Society of Cardiology. Published by Elsevier B.V. All rights reserved. doi:10.1016/S1474-5151(03)00091-4

Journal

European Journal of Cardiovascular NursingOxford University Press

Published: Dec 1, 2003

There are no references for this article.